Palladium (II) compounds containing oximes as promising antitumor agents for the treatment of osteosarcoma: An in vitro and in vivo comparative study with cisplatin
THR Pereira, TR de Moura, MRM Santos… - European Journal of …, 2024 - Elsevier
Drug resistance, evasion of cell death and metastasis are factors that contribute to the low
cure rate and disease-free survival in osteosarcomas (OS). In this study, we demonstrated …
cure rate and disease-free survival in osteosarcomas (OS). In this study, we demonstrated …
Palladium (II) compounds containing oximes as promising antitumor agents for the treatment of osteosarcoma: An in vitro and in vivo comparative study with cisplatin.
THR Pereira, TR de Moura, MRM Santos… - European Journal of …, 2023 - europepmc.org
Drug resistance, evasion of cell death and metastasis are factors that contribute to the low
cure rate and disease-free survival in osteosarcomas (OS). In this study, we demonstrated …
cure rate and disease-free survival in osteosarcomas (OS). In this study, we demonstrated …
Palladium (II) compounds containing oximes as promising antitumor agents for the treatment of osteosarcoma: An in vitro and in vivo comparative study with cisplatin
THR Pereira, TR de Moura, MRM Santos… - European journal of … - pubmed.ncbi.nlm.nih.gov
Drug resistance, evasion of cell death and metastasis are factors that contribute to the low
cure rate and disease-free survival in osteosarcomas (OS). In this study, we demonstrated …
cure rate and disease-free survival in osteosarcomas (OS). In this study, we demonstrated …